+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Predictive Genetics Market by Technology, Test Type, Application, End User, Product Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5470772
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The predictive genetics market is transforming clinical practice as advances in genomics, bioinformatics, and digital health drive new capabilities in disease risk assessment and personalized care. For senior leaders, aligning with this evolution requires insight into the commercial, technological, and regulatory forces actively shaping sector direction and competitive advantage.

Market Snapshot: Predictive Genetics Market Growth and Trajectory

The Predictive Genetics Market grew from USD 1.47 billion in 2024 to USD 1.75 billion in 2025. It is expected to continue growing at a CAGR of 18.36%, reaching USD 4.06 billion by 2030. This substantial expansion is driven by rapid adoption of next-generation sequencing, rising demand for tailored risk screening, and the integration of artificial intelligence tools that streamline complex genomic interpretation across healthcare networks. Momentum is also encouraged by widening direct-to-consumer access and changes in care delivery models across mature and emerging markets.

Scope & Segmentation: In-Depth Coverage of the Predictive Genetics Landscape

  • Technologies: Microarray (comparative genomic hybridization, expression microarray), next-generation sequencing (targeted sequencing, whole exome sequencing, whole genome sequencing), polymerase chain reaction (digital PCR, real-time PCR), Sanger sequencing.
  • Test Types: Cancer screening (BRCA, colorectal, lung), carrier screening (expanded, single gene), pharmacogenomics (CYP, drug metabolism), prenatal testing (invasive, noninvasive), risk assessment (cardiovascular, neurodegenerative).
  • Applications: Oncology, cardiovascular disease, infectious diseases, neurological disorders, rare diseases.
  • End Users: Academic research institutes, diagnostic laboratories, direct-to-consumer channels, hospitals.
  • Product Types: Consumables, instruments, services (genetic counseling, sequencing, testing), software.
  • Geographic Regions: Americas (United States – including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio – Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Leading Companies: Myriad Genetics, Invitae, Natera, 23andMe, Fulgent Genetics, Guardant Health, Color Health, Helix OpCo, Gene by Gene, Genomic Prediction.

Key Takeaways for Senior Decision-Makers

  • Integration of next-generation sequencing and AI-driven analytics continues to boost the predictive power and scalability of genetic testing solutions in both clinical care and research.
  • Shifting regulatory landscapes create opportunities and challenges, as streamlined approval pathways enable faster market entry but require enhanced compliance management and real-time monitoring of evolving standards.
  • Expansion in direct-to-consumer and hospital channels is democratizing access, but intensifies focus on clinical validation, data security, and ethical management of individual genetic risk information.
  • Diversification in technology platforms, testing modalities, and product offerings allows stakeholders to target underserved niches and adapt to swiftly changing demand across regions and clinical domains.
  • Collaborations across reagent, hardware, service, and software providers are crucial for building resilient supply chains, accelerating assay development, and delivering robust end-to-end genomic solutions.
  • Strategic investments in modular and scalable infrastructure position organizations to respond efficiently to shifting clinical requirements and application trends in predictive genomics.

Tariff Impact: Navigating US Trade Policy Shifts

US tariff measures introduced in 2025 are projected to increase landed costs for laboratory equipment, consumables, and reagents critical to predictive genetics workflows. Industry participants are responding by prioritizing localization and domestic production, adopting nearshoring and onshore contract manufacturing, and restructuring sourcing strategies to offset operational risk. This environment amplifies the need for proactive supplier partnerships and investments in domestic capabilities, particularly for emerging market entrants and smaller laboratories navigating increased price pressure.

Methodology & Data Sources

This predictive genetics market analysis is founded on blended secondary research, expert interviews, and advanced analytics. Data triangulation ensures reliable segmentation insights, while expert panel review and rigorous quality controls underpin the accuracy and stakeholder relevance of every finding.

Why This Report Matters for Strategic Leadership

  • Delivers actionable insight into competitive positioning and growth opportunities across regions, segments, and user groups.
  • Helps executive teams anticipate policy, regulatory, and technology shifts shaping risk and investment priorities in predictive genetics.
  • Equips stakeholders to optimize resource allocation and refine go-to-market strategies responsive to global adoption trends and local requirements.

Conclusion

The predictive genetics market is rapidly evolving, presenting new pathways for clinical and commercial value creation. Stakeholders prepared to adapt strategies to technology, policy, and market shifts will secure sustainable growth and leadership in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Predictive Genetics Market, by Technology
8.1. Introduction
8.2. Microarray
8.2.1. Comparative Genomic Hybridization
8.2.2. Expression Microarray
8.3. Next Generation Sequencing
8.3.1. Targeted Sequencing
8.3.2. Whole Exome Sequencing
8.3.3. Whole Genome Sequencing
8.4. Polymerase Chain Reaction
8.4.1. Digital PCR
8.4.2. Real Time PCR
8.5. Sanger Sequencing
9. Predictive Genetics Market, by Test Type
9.1. Introduction
9.2. Cancer Screening
9.2.1. BRCA Testing
9.2.2. Colorectal Cancer Screening
9.2.3. Lung Cancer Screening
9.3. Carrier Screening
9.3.1. Expanded Carrier
9.3.2. Single Gene Carrier
9.4. Pharmacogenomics
9.4.1. CYP Testing
9.4.2. Drug Metabolism Testing
9.5. Prenatal Testing
9.5.1. Invasive Prenatal Testing
9.5.2. Non Invasive Prenatal Testing
9.6. Risk Assessment
9.6.1. Cardiovascular Risk
9.6.2. Neurodegenerative Risk
10. Predictive Genetics Market, by Application
10.1. Introduction
10.2. Cardiovascular
10.2.1. Heart Disease
10.2.2. Stroke
10.3. Infectious Diseases
10.4. Neurological Disorders
10.5. Oncology
10.5.1. Breast Cancer
10.5.2. Colorectal Cancer
10.5.3. Lung Cancer
10.6. Rare Diseases
11. Predictive Genetics Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Diagnostic Laboratories
11.4. Direct to Consumer
11.5. Hospitals
12. Predictive Genetics Market, by Product Type
12.1. Introduction
12.2. Consumables
12.3. Instruments
12.4. Services
12.4.1. Genetic Counseling
12.4.2. Sequencing Service
12.4.2.1. NGS Service
12.4.2.2. PCR Service
12.4.3. Testing Service
12.5. Software
13. Americas Predictive Genetics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Predictive Genetics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Predictive Genetics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Myriad Genetics, Inc.
16.3.2. Invitae Corporation
16.3.3. Natera, Inc.
16.3.4. 23andMe Holding Co.
16.3.5. Fulgent Genetics, Inc.
16.3.6. Guardant Health, Inc.
16.3.7. Color Health, Inc.
16.3.8. Helix OpCo, Inc.
16.3.9. Gene by Gene, Ltd.
16.3.10. Genomic Prediction, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PREDICTIVE GENETICS MARKET MULTI-CURRENCY
FIGURE 2. PREDICTIVE GENETICS MARKET MULTI-LANGUAGE
FIGURE 3. PREDICTIVE GENETICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PREDICTIVE GENETICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PREDICTIVE GENETICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PREDICTIVE GENETICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PREDICTIVE GENETICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PREDICTIVE GENETICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY EXPRESSION MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY BRCA TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY COLORECTAL CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY LUNG CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY EXPANDED CARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY SINGLE GENE CARRIER, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CYP TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY DRUG METABOLISM TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY INVASIVE PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY NON INVASIVE PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR RISK, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY NEURODEGENERATIVE RISK, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY HEART DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY GENETIC COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY NGS SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY PCR SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY TESTING SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL PREDICTIVE GENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES PREDICTIVE GENETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 109. CANADA PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. CANADA PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 111. CANADA PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 112. CANADA PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 113. CANADA PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 114. CANADA PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 115. CANADA PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 116. CANADA PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 117. CANADA PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 118. CANADA PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 119. CANADA PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. CANADA PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 121. CANADA PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 122. CANADA PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. CANADA PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. CANADA PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. CANADA PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 128. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 129. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 130. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 132. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 133. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 135. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 136. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 138. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 139. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 142. MEXICO PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA PREDICTIVE GENETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 212. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 214. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 215. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 216. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 218. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 219. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 221. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 222. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 224. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 225. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 228. GERMANY PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 231. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 232. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 233. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 234. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 235. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 236. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 237. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 238. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 239. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 241. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 242. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 244. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. FRANCE PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 263. ITALY PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. ITALY PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 265. ITALY PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 266. ITALY PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 267. ITALY PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 268. ITALY PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 269. ITALY PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 270. ITALY PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 271. ITALY PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 272. ITALY PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 273. ITALY PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ITALY PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 275. ITALY PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 276. ITALY PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. ITALY PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. ITALY PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 279. ITALY PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 280. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 282. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 283. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 284. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 285. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 286. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 287. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 289. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 290. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 292. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 293. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 296. SPAIN PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 318. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY CARRIER SCREENING, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY PHARMACOGENOMICS, 2018-2030 (USD MILLION)
TABLE 322. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY PRENATAL TESTING, 2018-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY RISK ASSESSMENT, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA PREDICTIVE GENETICS MARKET SIZE, BY SEQUENCING SERVICE, 2018-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA PREDICTIVE GENETICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. SOUTH AFRICA PREDICTIVE GENETICS MARKET SIZE, BY MICROARRAY, 2018-2030 (USD MILLION)
TABL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Predictive Genetics market report include:
  • Myriad Genetics, Inc.
  • Invitae Corporation
  • Natera, Inc.
  • 23andMe Holding Co.
  • Fulgent Genetics, Inc.
  • Guardant Health, Inc.
  • Color Health, Inc.
  • Helix OpCo, Inc.
  • Gene by Gene, Ltd.
  • Genomic Prediction, Inc.

Table Information